ALYREF associated with immune infiltration is a prognostic biomarker in hepatocellular carcinoma

BACKGROUND: Although ALYREF has been demonstrated to have a role in a number of malignancies, its role in hepatocellular carcinoma (HCC) has received little attention. Our objective was to research at the prognostic value, biological role and relevance of ALYREF to the immune system in HCC. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhen-Zhen, Meng, Tao, Yang, Ming-Ya, Wang, Wei, Zhang, Yan, Liu, Yu, Han, An-Qi, Wu, Jin, Wang, Hui-xiao, Qian, Bo, Zhu, Li-Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9079359/
https://www.ncbi.nlm.nih.gov/pubmed/35523010
http://dx.doi.org/10.1016/j.tranon.2022.101441

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9079359/
https://www.ncbi.nlm.nih.gov/pubmed/35523010
http://dx.doi.org/10.1016/j.tranon.2022.101441

Ejemplares similares